Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients.

Burr AR, Harari PM, Ko HC, Chen S, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

Otorhinolaryngol Head Neck Surg. 2018;3(1). doi: 10.15761/OHNS.1000160. Epub 2018 Feb 24.

2.

Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center.

Blitzer GC, Rosenberg SA, Anderson BM, McCulloch TM, Wieland AM, Hartig GK, Bruce JY, Witek ME, Kimple RJ, Harari PM.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):146-148. doi: 10.1016/j.ijrobp.2018.05.007. Epub 2018 Jul 3. No abstract available.

PMID:
29980415
3.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
4.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx-Reply.

Witek ME, Hartig GK, Harari PM.

JAMA Otolaryngol Head Neck Surg. 2018 Jun 1;144(6):543. doi: 10.1001/jamaoto.2018.0083. No abstract available.

PMID:
29621382
5.

Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer.

Davidson SM, Ko HC, Harari PM, Wieland AM, Chen S, Baschnagel AM, Kimple RJ, Witek ME.

Otolaryngol Head Neck Surg. 2018 Sep;159(3):456-465. doi: 10.1177/0194599818766035. Epub 2018 Apr 3.

PMID:
29611770
6.

Are All Head and Neck Squamous Cell Carcinomas Created Equal?

Witek ME.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1059-1060. doi: 10.1016/j.ijrobp.2017.05.010. No abstract available.

PMID:
29165272
7.

Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.

Ko HC, Harari PM, Chen S, Wieland AM, Yu M, Baschnagel AM, Kimple RJ, Witek ME.

JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1126-1133. doi: 10.1001/jamaoto.2017.1756.

8.

Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Ko HC, Harari PM, Sacotte RM, Chen S, Wieland AM, Yu M, Baschnagel AM, Bruce JY, Kimple RJ, Witek ME.

J Cancer Res Clin Oncol. 2017 Nov;143(11):2341-2350. doi: 10.1007/s00432-017-2481-8. Epub 2017 Jul 27.

PMID:
28752235
9.

Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database.

Ko HC, Chen S, Wieland AM, Yu M, Baschnagel AM, Hartig GK, Harari PM, Witek ME.

Head Neck. 2017 Nov;39(11):2159-2170. doi: 10.1002/hed.24881. Epub 2017 Jul 24.

10.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
11.

Small cell carcinoma of the head and neck: An analysis of the National Cancer Database.

Pointer KB, Ko HC, Brower JV, Witek ME, Kimple RJ, Lloyd RV, Harari PM, Baschnagel AM.

Oral Oncol. 2017 Jun;69:92-98. doi: 10.1016/j.oraloncology.2017.04.009. Epub 2017 Apr 25.

12.

Outcomes for patients with head and neck squamous cell carcinoma presenting with N3 nodal disease.

Witek ME, Wieland AM, Chen S, Kennedy TA, Hullett CR, Liang E, Hartig GK, Kimple RJ, Harari PM.

Cancers Head Neck. 2017;2. pii: 8. doi: 10.1186/s41199-017-0027-z. Epub 2017 Nov 14.

13.

Pancreatic cancer planning: Complex conformal vs modulated therapies.

Chapman KL, Witek ME, Chen H, Showalter TN, Bar-Ad V, Harrison AS.

Med Dosim. 2016 Summer;41(2):100-4. doi: 10.1016/j.meddos.2015.10.002. Epub 2016 Jan 29.

PMID:
26831922
14.

Is financial literacy necessary for radiation oncology residents?

Witek M, Siglin J, Malatesta T, Snook A, Gressen E, Rudoler S, Bar-Ad V, Fisher S.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):986-7. doi: 10.1016/j.ijrobp.2014.08.010. No abstract available.

PMID:
25539362
15.

Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapy.

Siglin J, Champ CE, Vakhnenko Y, Witek ME, Peng C, Zaorsky NG, Harrison AS, Shi W.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):378-83. doi: 10.1016/j.prro.2013.11.008. Epub 2014 Jan 10.

PMID:
25407858
16.

A novel CDX2 isoform regulates alternative splicing.

Witek ME, Snook AE, Lin JE, Blomain ES, Xiang B, Magee MS, Waldman SA.

PLoS One. 2014 Aug 7;9(8):e104293. doi: 10.1371/journal.pone.0104293. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e112164. Magee, Michael [corrected to Magee, Michael S].

17.

Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy.

Witek M, Vahknenko Y, Siglin J, Harrison A, Xiao Y, Lui H, Andrews D, Shi W.

Int J Med Phys Clin Eng Radiat Oncol. 2014 Aug;3(3):176-182. doi: 10.4236/ijmpcero.2014.33023.

18.

Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.

Palmer JD, Zaorsky NG, Witek M, Lu B.

J Thorac Dis. 2014 Apr;6(4):387-98. doi: 10.3978/j.issn.2072-1439.2013.12.04. Review.

19.

Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.

Witek M, Blomain ES, Magee MS, Xiang B, Waldman SA, Snook AE.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1188-95. doi: 10.1016/j.ijrobp.2013.12.043.

20.

Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.

Bar-Ad V, Leiby B, Witek M, Xiao Y, Cui Y, Dai Y, Cao J, Axelrod R, Campling B, Both S, Werner-Wasik M.

Am J Clin Oncol. 2014 Oct;37(5):433-7. doi: 10.1097/COC.0b013e31827de7a2.

PMID:
23388558
21.

Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.

Shen X, Andrews DW, Sergott RC, Evans JJ, Curran WJ, Machtay M, Fragoso R, Eldredge H, Champ CE, Witek M, Mishra MV, Dicker AP, Werner-Wasik M.

Radiat Oncol. 2012 Dec 28;7:225. doi: 10.1186/1748-717X-7-225.

22.

The transcription factor encyclopedia.

Yusuf D, Butland SL, Swanson MI, Bolotin E, Ticoll A, Cheung WA, Zhang XY, Dickman CT, Fulton DL, Lim JS, Schnabl JM, Ramos OH, Vasseur-Cognet M, de Leeuw CN, Simpson EM, Ryffel GU, Lam EW, Kist R, Wilson MS, Marco-Ferreres R, Brosens JJ, Beccari LL, Bovolenta P, Benayoun BA, Monteiro LJ, Schwenen HD, Grontved L, Wederell E, Mandrup S, Veitia RA, Chakravarthy H, Hoodless PA, Mancarelli MM, Torbett BE, Banham AH, Reddy SP, Cullum RL, Liedtke M, Tschan MP, Vaz M, Rizzino A, Zannini M, Frietze S, Farnham PJ, Eijkelenboom A, Brown PJ, Laperrière D, Leprince D, de Cristofaro T, Prince KL, Putker M, del Peso L, Camenisch G, Wenger RH, Mikula M, Rozendaal M, Mader S, Ostrowski J, Rhodes SJ, Van Rechem C, Boulay G, Olechnowicz SW, Breslin MB, Lan MS, Nanan KK, Wegner M, Hou J, Mullen RD, Colvin SC, Noy PJ, Webb CF, Witek ME, Ferrell S, Daniel JM, Park J, Waldman SA, Peet DJ, Taggart M, Jayaraman PS, Karrich JJ, Blom B, Vesuna F, O'Geen H, Sun Y, Gronostajski RM, Woodcroft MW, Hough MR, Chen E, Europe-Finner GN, Karolczak-Bayatti M, Bailey J, Hankinson O, Raman V, LeBrun DP, Biswal S, Harvey CJ, DeBruyne JP, Hogenesch JB, Hevner RF, Héligon C, Luo XM, Blank MC, Millen KJ, Sharlin DS, Forrest D, Dahlman-Wright K, Zhao C, Mishima Y, Sinha S, Chakrabarti R, Portales-Casamar E, Sladek FM, Bradley PH, Wasserman WW.

Genome Biol. 2012;13(3):R24. doi: 10.1186/gb-2012-13-3-r24.

23.

Bile acids initiate lineage-addicted gastroesophageal tumorigenesis by suppressing the EGF receptor-AKT axis.

Gong L, Debruyne PR, Witek M, Nielsen K, Snook A, Lin JE, Bombonati A, Palazzo J, Schulz S, Waldman SA.

Clin Transl Sci. 2009 Aug;2(4):286-93. doi: 10.1111/j.1752-8062.2009.00131.x.

24.

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.

Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA.

Clin Cancer Res. 2006 Aug 1;12(15):4545-52.

25.

Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells.

Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, Domon-Cell C, Palazzo JP, Freund JN, Li P, Pitari GM, Schulz S, Waldman SA.

Gastroenterology. 2006 Apr;130(4):1191-206.

PMID:
16618413
26.

The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.

Witek ME, Nielsen K, Walters R, Hyslop T, Palazzo J, Schulz S, Waldman SA.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8549-56.

Supplemental Content

Loading ...
Support Center